• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光化性角化病和皮肤鳞状细胞癌患者的 microRNAs 分析。

Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.

机构信息

Department of Dermatology, Poznan University of Medical Sciences, Poznan, Poland.

Department of Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland.

出版信息

Arch Dermatol Res. 2022 Apr;314(3):257-266. doi: 10.1007/s00403-021-02221-2. Epub 2021 Apr 4.

DOI:10.1007/s00403-021-02221-2
PMID:33813600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8918171/
Abstract

Actinic keratosis (AK) is a common skin lesion often defined as premalignant with more evidence indicating it as early stage of cutaneous squamous cell carcinoma (cSCC). The AK may remain stable, transform towards incisive cSCC or in some cases revert spontaneously. Several different underlying conditions can increase risk of cSCC, however, advanced age represents major risk of AK and its progression towards cSCC indicating increased risk during chronological aging. Importantly, AK and cSCC are characterized by similar genetic profile, which lead researchers to search for novel biomarkers allowing early detection. As skin sampling is often invasive and causes scaring, in the current study, we investigated a novel approach to establish potential blood circulating genetic markers in patients diagnosed with AK and cSCC. Based on clinical diagnosis and dermoscopy, we recruited 13 patients with AK (divided into two groups: the first included patients with no more than three lesions, the second group included patients with at least ten lesions) and two additional individuals diagnosed with cSCC. Deep sequencing analysis of serum circulating miRNAs detected a total of 68 expressed miRNAs. Further analysis indicated 2 regulated miRNAs for AK cohort and 12 miRNAs for cSCC patients, while there were 26 miRNAs differentially regulated between cSCC and AK patients. There was also one commonly regulated miRNA between AK and cSCC patients and ten miRNAs that were regulated in cSCC when compared with both control and AK patients. We did not observe any differences between the AK groups. In conclusion, our analysis detected in circulation some miRNA that were previously recognized as important in AK, cSCC, and other type of skin cancer supporting this approach as potential non-invasive diagnosis of AK and cSCC.

摘要

光化性角化病(AK)是一种常见的皮肤病变,通常被定义为癌前病变,更多的证据表明它处于皮肤鳞状细胞癌(cSCC)的早期阶段。AK 可能保持稳定,向侵袭性 cSCC 转化,或者在某些情况下自发消退。几种不同的潜在情况会增加 cSCC 的风险,然而,年龄增长是 AK 及其向 cSCC 进展的主要风险因素,表明随着时间的推移,风险增加。重要的是,AK 和 cSCC 具有相似的遗传特征,这促使研究人员寻找新的生物标志物以进行早期检测。由于皮肤采样通常具有侵入性并会导致疤痕,因此在目前的研究中,我们研究了一种新方法,以在诊断为 AK 和 cSCC 的患者中建立潜在的血液循环遗传标志物。根据临床诊断和皮肤镜检查,我们招募了 13 名 AK 患者(分为两组:第一组包括不超过三个病变的患者,第二组包括至少十个病变的患者)和另外两名诊断为 cSCC 的患者。对血清循环 miRNA 进行深度测序分析,共检测到 68 个表达的 miRNA。进一步分析表明,AK 队列有 2 个调节 miRNA,cSCC 患者有 12 个 miRNA,而 cSCC 患者与 AK 患者之间有 26 个 miRNA 差异调节。AK 和 cSCC 患者之间也有一个共同调节的 miRNA,与对照和 AK 患者相比,有 10 个 miRNA 在 cSCC 中受到调节。我们没有观察到 AK 组之间的任何差异。总之,我们的分析在循环中检测到了一些 miRNA,这些 miRNA 以前被认为在 AK、cSCC 和其他类型的皮肤癌中很重要,支持这种方法作为 AK 和 cSCC 的潜在非侵入性诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f103/8918171/1fb2963bf9c5/403_2021_2221_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f103/8918171/cd70bb064f07/403_2021_2221_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f103/8918171/4ddc489e749f/403_2021_2221_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f103/8918171/1fb2963bf9c5/403_2021_2221_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f103/8918171/cd70bb064f07/403_2021_2221_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f103/8918171/4ddc489e749f/403_2021_2221_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f103/8918171/1fb2963bf9c5/403_2021_2221_Fig3_HTML.jpg

相似文献

1
Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.光化性角化病和皮肤鳞状细胞癌患者的 microRNAs 分析。
Arch Dermatol Res. 2022 Apr;314(3):257-266. doi: 10.1007/s00403-021-02221-2. Epub 2021 Apr 4.
2
Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.靶向深度测序揭示光化性角化病/原位皮肤鳞状细胞癌和皮肤鳞状细胞癌的基因组改变。
Exp Dermatol. 2023 Apr;32(4):447-456. doi: 10.1111/exd.14730. Epub 2022 Dec 26.
3
Pathogenic genes related to the progression of actinic keratoses to cutaneous squamous cell carcinoma.与光化性角化病进展为皮肤鳞状细胞癌相关的致病基因。
Int J Dermatol. 2018 Oct;57(10):1208-1217. doi: 10.1111/ijd.14131. Epub 2018 Aug 13.
4
Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.非标记 LC-MS/MS 技术在光化性角化病、鲍恩病和皮肤鳞状细胞癌中的差异蛋白质组学分析。
J Dermatol Sci. 2018 Jul;91(1):69-78. doi: 10.1016/j.jdermsci.2018.04.006. Epub 2018 Apr 10.
5
Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling.通过转录组分析鉴定出光化性角化病和皮肤鳞状细胞癌之间的关键差异。
Br J Cancer. 2014 Jan 21;110(2):520-9. doi: 10.1038/bjc.2013.760. Epub 2013 Dec 12.
6
Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma.单细胞测序凸显光化性角化病和皮肤鳞状细胞癌的异质性和恶性进展。
Elife. 2023 Dec 15;12:e85270. doi: 10.7554/eLife.85270.
7
Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma.日光性皮肤损伤与随后发生的皮肤鳞状细胞癌的 10 年随访。
JAMA Dermatol. 2021 May 1;157(5):559-565. doi: 10.1001/jamadermatol.2021.0372.
8
MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.微小RNA-204沉默在表皮内至侵袭性皮肤鳞状细胞癌进展过程中的作用
Mol Cancer. 2016 Jul 25;15(1):53. doi: 10.1186/s12943-016-0537-z.
9
Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.MCM2 在光化性角化病和皮肤鳞状细胞癌中的增殖标记物表达。
In Vivo. 2022 May-Jun;36(3):1245-1251. doi: 10.21873/invivo.12823.
10
Gene expression landscape of cutaneous squamous cell carcinoma progression.皮肤鳞状细胞癌进展的基因表达图谱
Br J Dermatol. 2024 Oct 17;191(5):760-774. doi: 10.1093/bjd/ljae249.

引用本文的文献

1
From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments.从光化性角化病到皮肤鳞状细胞癌:关键发病机制与治疗方法
Front Immunol. 2025 Jan 24;16:1518633. doi: 10.3389/fimmu.2025.1518633. eCollection 2025.
2
MicroRNA expression profiling of cutaneous squamous cell carcinomas and precursor lesions.皮肤鳞状细胞癌及前驱病变的微小RNA表达谱分析
Skin Health Dis. 2024 Mar 16;4(3):e360. doi: 10.1002/ski2.360. eCollection 2024 Jun.
3
MicroRNAs Differentially Expressed in Actinic Keratosis and Healthy Skin Scrapings.

本文引用的文献

1
miRNAs in the Diagnosis and Prognosis of Skin Cancer.微小RNA在皮肤癌诊断和预后中的作用
Front Cell Dev Biol. 2020 Feb 28;8:71. doi: 10.3389/fcell.2020.00071. eCollection 2020.
2
Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.联合检测血清中三种 miRNA 作为 HNSCC 的有效诊断生物标志物。
EBioMedicine. 2019 Dec;50:135-143. doi: 10.1016/j.ebiom.2019.11.016. Epub 2019 Nov 26.
3
MicroRNA regulation in colorectal cancer tissue and serum.结直肠癌组织和血清中的 microRNA 调控。
日光性角化病和健康皮肤刮屑中差异表达的微小RNA
Biomedicines. 2023 Jun 15;11(6):1719. doi: 10.3390/biomedicines11061719.
PLoS One. 2019 Aug 30;14(8):e0222013. doi: 10.1371/journal.pone.0222013. eCollection 2019.
4
MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.微 RNA 在皮肤鳞状细胞癌中的失调。
Int J Mol Sci. 2019 May 2;20(9):2181. doi: 10.3390/ijms20092181.
5
Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis.细胞色素P450:多态性及其在癌症、糖尿病和动脉粥样硬化中的作用
Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2057-2070. doi: 10.22034/APJCP.2018.19.8.2057.
6
Pathogenic genes related to the progression of actinic keratoses to cutaneous squamous cell carcinoma.与光化性角化病进展为皮肤鳞状细胞癌相关的致病基因。
Int J Dermatol. 2018 Oct;57(10):1208-1217. doi: 10.1111/ijd.14131. Epub 2018 Aug 13.
7
Actinic keratosis - review for clinical practice.光化性角化病——临床实践综述。
Int J Dermatol. 2019 Apr;58(4):400-407. doi: 10.1111/ijd.14147. Epub 2018 Aug 2.
8
Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer.非小细胞肺癌中的组织和外泌体 miRNA 编辑。
Sci Rep. 2018 Jul 5;8(1):10222. doi: 10.1038/s41598-018-28528-1.
9
Blood Serum From Head and Neck Squamous Cell Carcinoma Patients Induces Altered MicroRNA and Target Gene Expression Profile in Treated Cells.头颈部鳞状细胞癌患者的血清可诱导处理细胞中微小RNA及靶基因表达谱的改变。
Front Oncol. 2018 Jun 11;8:217. doi: 10.3389/fonc.2018.00217. eCollection 2018.
10
Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine.循环 microRNA 生物标志物在黑色素瘤中的应用:个体化医学的工具与挑战。
Biomolecules. 2018 Apr 26;8(2):21. doi: 10.3390/biom8020021.